Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan

J Clin Microbiol. 2011 Mar;49(3):1017-24. doi: 10.1128/JCM.02149-10. Epub 2011 Jan 19.

Abstract

The major routes of hepatitis B virus (HBV) infection in Japan has been mother-to-child transmission (MTCT) and blood transfusion. However, HBV cases transmitted through sexual contact are increasing, especially among HIV-1-seropositive patients. To understand the molecular epidemiology of HBV in HBV/HIV-1 coinfection, we analyzed HBV genotypes and HIV-1 subtypes in HBV/HIV-1-coinfected patients at Nagoya Medical Center from 2003 to 2007. Among 394 HIV-1-infected Japanese men having sex with men (MSM) who were newly diagnosed during the study period, 31 (7.9%) tested positive for the hepatitis B virus surface antigen. HBV sequence analyses were successful in 26 cases, with 21 (80.7%) and 5 (19.3%) cases determined as genotypes A and C, respectively. Our finding that HBV genotype A was dominant in HIV-1-seropositive patients alerts clinicians to an alternative outbreak of HBV genotype A in the HIV-1-infected MSM population and a shift in HBV genotype from C to A in Japan. The narrow genetic diversity in genotype A cases suggests that genotype A has been recently introduced into the MSM population and that sexual contacts among MSM were more active than speculated from HIV-1 tree analyses. In addition, we found a lamivudine resistance mutation in one naïve case, suggesting a risk of drug-resistant HBV transmission. As genotype A infection has a higher risk than infection with other genotypes for individuals to become HBV carriers, prevention programs are urgently needed for the target population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / pharmacology*
  • Cluster Analysis
  • DNA, Viral / genetics
  • Disease Outbreaks*
  • Drug Resistance, Viral*
  • Female
  • Genetic Variation
  • Genotype
  • HIV Infections / complications*
  • HIV Infections / virology
  • HIV-1 / isolation & purification
  • Hepatitis B / epidemiology*
  • Hepatitis B / virology
  • Hepatitis B virus / classification
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / genetics
  • Hepatitis B virus / isolation & purification
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Phylogeny
  • Sequence Analysis, DNA

Substances

  • Antiviral Agents
  • DNA, Viral

Associated data

  • GENBANK/AB697487
  • GENBANK/AB697488
  • GENBANK/AB697489
  • GENBANK/AB697490
  • GENBANK/AB697491
  • GENBANK/AB697492
  • GENBANK/AB697493
  • GENBANK/AB697494
  • GENBANK/AB697495
  • GENBANK/AB697496
  • GENBANK/AB697497
  • GENBANK/AB697498
  • GENBANK/AB697499
  • GENBANK/AB697500
  • GENBANK/AB697501
  • GENBANK/AB697502
  • GENBANK/AB697503
  • GENBANK/AB697504
  • GENBANK/AB697505
  • GENBANK/AB697506
  • GENBANK/AB697507
  • GENBANK/AB697508
  • GENBANK/AB697509
  • GENBANK/AB697510
  • GENBANK/AB697511
  • GENBANK/AB697512